Literature DB >> 27614991

Radiotherapy of Cervical Cancer.

Dirk Vordermark1.   

Abstract

Curative-intent radical radiotherapy of cervical cancer consists of external-beam radiotherapy, brachytherapy, and concomitant chemotherapy with cisplatin. For each element, new developments aim to improve tumor control rates or treatment tolerance. Intensity-modulated radiotherapy (IMRT) has been shown to reduce gastrointestinal toxicity and can be used to selectively increase the radiotherapy dose. Individualized, image-guided brachytherapy enables better adaptation of high-dose volumes to the tumor extension. Intensification of concomitant or sequential systemic therapy is under evaluation.
© 2016 S. Karger GmbH, Freiburg.

Entities:  

Mesh:

Year:  2016        PMID: 27614991     DOI: 10.1159/000448902

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


  15 in total

Review 1.  Intensified Systemic Therapy Regimens in Combination With Definitive Radiation for Treatment of Cervical Cancer.

Authors:  Travis T Sims; Ann H Klopp
Journal:  Semin Radiat Oncol       Date:  2020-10       Impact factor: 5.934

2.  Influence of SIRT6 regulation of cellular glycometabolism on radiosensitivity of non-small-cell lung cancer A549 cells.

Authors:  Yong Cai; Zhaoying Sheng; Yun Chen; Jiying Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  PRKCI Mediates Radiosensitivity via the Hedgehog/GLI1 Pathway in Cervical Cancer.

Authors:  Zhuna Wu; Chunxian Huang; Ruixin Li; Hui Li; Huaiwu Lu; Zhongqiu Lin
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

4.  circ_0084927 promotes cervical carcinogenesis by sponging miR-1179 that suppresses CDK2, a cell cycle-related gene.

Authors:  Xinhua Qu; Liumei Zhu; Linlin Song; Shaohua Liu
Journal:  Cancer Cell Int       Date:  2020-07-21       Impact factor: 5.722

5.  Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.

Authors:  Caixia Gou; Pengbing Han; Jin Li; Liying Gao; Xuejuan Ji; Fang Dong; Qun Su; Yanping Zhang; Xiaofeng Liu
Journal:  Br J Radiol       Date:  2020-02-12       Impact factor: 3.039

6.  MAPK4 deletion enhances radiation effects and triggers synergistic lethality with simultaneous PARP1 inhibition in cervical cancer.

Authors:  Shuzhen Tian; Lili Lou; Mengyuan Tian; Guangping Lu; Jianghua Tian; Xi Chen
Journal:  J Exp Clin Cancer Res       Date:  2020-07-25

Review 7.  Electrical stimulation on adverse events caused by chemotherapy in patients with cervical cancer: A protocol for a systematic review of randomized controlled trial.

Authors:  Peng-Hui Dou; Dan-Feng Zhang; Cui-Hong Su; Xiao-Li Zhang; Ying-Jie Wu
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

Review 8.  The Roles of Hedgehog Signaling Pathway in Radioresistance of Cervical Cancer.

Authors:  Chang Liu; Rensheng Wang
Journal:  Dose Response       Date:  2019-10-28       Impact factor: 2.658

9.  Serum MicroRNAs Related with Chemoradiotherapy Resistance in Advanced-Stage Cervical Squamous Cell Carcinoma.

Authors:  Ying Han; Mei Liu; Ziyi Wang; Manni Huang; Ningzhi Xu; Lingying Wu
Journal:  Transl Oncol       Date:  2017-04-19       Impact factor: 4.243

10.  Knockdown of Ubiquitin-Specific Protease 53 Enhances the Radiosensitivity of Human Cervical Squamous Cell Carcinoma by Regulating DNA Damage-Binding Protein 2.

Authors:  Qifen Zhou; Xiongbo Yao; Chunlin Wu; Shaohua Chen; Dage Fan
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.